Stocklytics Platform
Asset logo for symbol XNCR
Xencor
XNCR60
$24.27arrow_drop_down1.09%-$0.26
Asset logo for symbol XNCR
XNCR60

$24.27

arrow_drop_down1.09%
Key Stats
Open$24.57
Prev. Close$24.57
EPS-3.18
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range23.92
24.60
52 Week Range15.31
31.36
Ratios
EPS-3.18
Fundamentals
Gross Profit-
Payout Ratio-
Industry average yield2.90%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

XNCR-
US Healthcare Sector-
US Market-
warning

XNCR / Market

XNCR lose to the US Market which returned 1.00% over the last twenty four hours.
warning

XNCR / Healthcare Sector

XNCR lose to the US Healthcare sector which returned 2.95% over the last twenty four hours.

Xencor (XNCR) Statistics

Xencor Inc (XNCR) is a biopharmaceutical company that focuses on the discovery and development of innovative antibody therapeutics. The company is known for its proprietary XmAb antibody engineering platform, which enables the creation of novel drug candidates with enhanced properties. XNCR is committed to advancing the field of immunology and improving the lives of patients with serious diseases.
When it comes to XNCR's stock statistics, investors can look at various metrics to evaluate the company's performance. For instance, valuation metrics provide insights into the company's market value relative to its earnings, revenue, or assets. These metrics include the price-to-earnings ratio (P/E), price-to-sales ratio (P/S), price-to-book ratio (P/B), and price-to-cash flow ratio (P/CF). Examining these metrics can help investors assess whether XNCR's stock is overvalued or undervalued compared to its peers or the sector as a whole.
add Xencor  to watchlist

Keep an eye on Xencor

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Xencor (XNCR) stock's performance compared to its sector and the market over the past year?

Over the past year, Xencor (XNCR) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.34%, Xencor has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 47.67%, it has fallen short of the market average. This comparison highlights Xencor 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Xencor (XNCR) stock?

The PE ratio for Xencor (XNCR) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Xencor (XNCR) stock?

The Earnings Per Share (EPS) for Xencor (XNCR), calculated on a diluted basis, is -$3.18. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Xencor (XNCR) stock?

The operating margin for Xencor (XNCR) is -581.54%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Xencor (XNCR) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Xencor (XNCR) is -$202.48M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Xencor (XNCR) have?

Xencor (XNCR) has a total debt of $86.59M. The net debt, which accounts for cash and cash equivalents against the total debt, is $57.56M.

Take Your Investments to a Whole New Level